Cost-Consequence Analysis Comparing Originator r-hFSH-alfa and Biosimilars for =4 Complete Ovarian Stimulation Cycles During Assisted Reproductive Technology Treatment: A Multi-Country Perspective
- DOI
- 10.1159/goi/aczag022
- Published
- 2026-10-29
- Container
- Gynecologic and Obstetric Investigation
- Publisher
- S. Karger AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1159/goi/aczag022,
title = {Cost-Consequence Analysis Comparing Originator r-hFSH-alfa and Biosimilars for =4 Complete Ovarian Stimulation Cycles During Assisted Reproductive Technology Treatment: A Multi-Country Perspective},
author = {Claudia Roeder and Roberta Longo and Jeroen Luyten and Juan-Enrique Schwarze and Kemal Uca and Cristina Masseria and Mackenzie Mills},
year = {2026},
journal = {Gynecologic and Obstetric Investigation},
doi = {10.1159/goi/aczag022},
url = {https://doi.org/10.1159/goi/aczag022}
}RIS
TY - JOUR TI - Cost-Consequence Analysis Comparing Originator r-hFSH-alfa and Biosimilars for =4 Complete Ovarian Stimulation Cycles During Assisted Reproductive Technology Treatment: A Multi-Country Perspective AU - Claudia Roeder AU - Roberta Longo AU - Jeroen Luyten AU - Juan-Enrique Schwarze AU - Kemal Uca AU - Cristina Masseria AU - Mackenzie Mills PY - 2026 JO - Gynecologic and Obstetric Investigation DO - 10.1159/goi/aczag022 UR - https://doi.org/10.1159/goi/aczag022 ER -
APA
Roeder, C., Longo, R., Luyten, J., Schwarze, J., Uca, K., Masseria, C., & Mills, M. (2026). Cost-Consequence Analysis Comparing Originator r-hFSH-alfa and Biosimilars for =4 Complete Ovarian Stimulation Cycles During Assisted Reproductive Technology Treatment: A Multi-Country Perspective. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/goi/aczag022
Source records
- crossref · retrieved 2026-11-10T13:05:40.229Z